Evidence map›Paper›PMID 29287913›Full record

ArticleAntiviral research2018

Evaluation of ODE-Bn-PMEG, an acyclic nucleoside phosphonate prodrug, as an antiviral against productive HPV infection in 3D organotypic epithelial cultures.

N Sanjib Banerjee, Hsu-Kun Wang, James R Beadle, Karl Y Hostetler, Louise T Chow

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antiviral research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Targeting DNA Damage Response as a Strategy to Treat HPV Infections.International journal of molecular sciences · 2019
    Article
  6. Article
  7. Vorinostat, a pan-HDAC inhibitor, abrogates productive HPV-18 DNA amplification.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

N Sanjib BanerjeeDepartment of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35294-0005, USA. Electronic address: banerjee@uab.edu.
Hsu-Kun WangDepartment of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35294-0005, USA.
James R BeadleDepartment of Medicine, University of California, San Diego, La Jolla, CA 92093-0676, USA.
Karl Y HostetlerDepartment of Medicine, University of California, San Diego, La Jolla, CA 92093-0676, USA.
Louise T ChowDepartment of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35294-0005, USA.

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
MECHANISMS OF HUMAN PAPILLOMAVIRUS DNA REPLICATIONR01CA083679 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CHOW, LOUISE T · 1999 to 2015
$5.1M
NCI NIH HHS P30 CA013148NCI NIH HHS R01 CA083679NIAID NIH HHS HHSN272201100016C
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntiviral AgentsDNA DamageDNA ReplicationDNA, ViralDrug Evaluation, PreclinicalGuanineHumansOrganophosphonatesPapillomaviridaeProdrugsVirus ReplicationAntiviral AgentsDNA, ViralGuanineoctadecyloxyethyl 9-(2-(phosphonomethoxy)ethyl)guanineOrganophosphonatesProdrugs

Identifiers

PMID29287913
PMCPMC5800947

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.